8 May 2024 in Universitas Scientiarum
Low-density polyethylene (LDPE) is a widely used polymer due to its chemical resistance, high flexibility, and mechanical properties. However, its low degradation rate, coupled with its low lifespan and widespread accumulation, poses significant environmental and public health concerns. This study presents a biodegradation model for LDPE using a suspension bioreactor, which could serve as a biological treatment alternative before polymer disposal. In our model, an initial culture of Aspergillus brasiliensis metabolized the carbon within the polymer structure and used it as an energy source, leading to LPDE biodegradation and mineralization. The procedure took place in a laboratory-scale bioreactor prototype under aerobic conditions and submerged liquid fermentation. After one month of culture, a biodegradation percentage of 1:890:56 % was reached. The treated materials were analyzed by scanning electron microscopy (SEM) and fourier transform infrared spectroscopy (FTIR). We found evidence of biodegradation, colonization of the material, and biofilm formation. This research provides preliminary data on the biodegradation of LDPE under submerged liquid fermentation, marking an initial phase in the development of a prototype for polymer biodegradation.
27 October 2026 in bioRxiv
SMSusana Alexandra Costa Maia
Susana Alexandra Costa Maia
+9
Biomanufactured cell therapies are delivering a step-change in modern medicine, but their high costs have prevented widespread adoption. Cultured red blood cells (cRBCs) are one type of cell therapy in clinical trials for off-the-shelf blood transfusion but remain limited by the exorbitant costs of manufacturing trillions of RBCs required for a blood transfusion. These costs could be mitigated if culture platforms could grow cells at higher density, like those found in the bone marrow, requiring less media and lower concentrations of expensive growth factors per cell. We engineered melt electrowritten (MEW) polycaprolactone (PCL) scaffolds in geometries which imitate marrow trabeculae structures and were then plasma-treated to enable peripheral blood mononuclear cells (PB MNC) attachment. PB MNC monocytes first adhered to the scaffold and rapidly differentiated into CD68 + macrophage-like cells. These macrophage-loaded scaffolds adhered CD71 + erythroblasts, which then grew from 10 to 25% between days 4 and 8 and produced CD235a + erythroid cells by day 20, under erythrogenic culture conditions. MEW PCL scaffolds in trabecular-like geometries had greater surface area, adhered more macrophages, and generated more erythroblasts than traditional MEW crosshatch geometries. The MEW scaffolds continuously released less-adherent cells to the supernatant, providing a 74% increase in supernatant cell numbers versus liquid suspension controls with identical cell seeding numbers and media volumes. High-cell-density scaffolds exhibited increased metabolism and endogenous production of self-supportive cytokines, which may offer cost-saving opportunities through future media optimisation. This study reports marrow trabeculae-mimetic MEW PCL designs capable of selectively adhering PB MN cells to develop macrophage-coated scaffolds, which provided physical and paracrine support for cRBC production. This high-cell-density culture platform may be useful for future cell therapy biomanufacturing protocols.